U.S. Physical Therapy, Inc. (NYSE:USPH) Stock Holdings Lifted by GAMMA Investing LLC

GAMMA Investing LLC boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 27,856.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,301 shares of the company's stock after acquiring an additional 12,257 shares during the quarter. GAMMA Investing LLC owned about 0.08% of U.S. Physical Therapy worth $890,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of USPH. Principal Securities Inc. boosted its holdings in U.S. Physical Therapy by 24.7% in the 4th quarter. Principal Securities Inc. now owns 3,293 shares of the company's stock worth $292,000 after acquiring an additional 653 shares during the period. Principal Financial Group Inc. raised its position in shares of U.S. Physical Therapy by 4.1% during the 4th quarter. Principal Financial Group Inc. now owns 83,091 shares of the company's stock valued at $7,371,000 after acquiring an additional 3,274 shares in the last quarter. AlphaCentric Advisors LLC acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $479,000. Truist Financial Corp raised its position in shares of U.S. Physical Therapy by 60.1% during the 4th quarter. Truist Financial Corp now owns 17,937 shares of the company's stock valued at $1,591,000 after acquiring an additional 6,736 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its position in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares in the last quarter.

U.S. Physical Therapy Price Performance

USPH stock traded down $0.56 during trading on Wednesday, hitting $73.89. The company had a trading volume of 124,174 shares, compared to its average volume of 117,678. The business has a 50 day moving average of $73.65 and a 200 day moving average of $81.12. The firm has a market capitalization of $1.12 billion, a price-to-earnings ratio of 33.89, a P/E/G ratio of 3.75 and a beta of 1.45. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same period in the previous year, the firm earned $0.51 EPS. U.S. Physical Therapy's revenue was up 18.0% on a year-over-year basis. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Buying and Selling at U.S. Physical Therapy

In related news, Director Nancy Ham sold 400 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director now directly owns 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Barrington Research lowered their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. JMP Securities restated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. lowered their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.